Top in cardiology: Metformin use in prediabetes; sleep apnea and CVD
Click Here to Manage Email Alerts
In a recent study, researchers found no between-group differences in myocardial infarction, stroke or cardiovascular death among patients with prediabetes who received metformin, a lifestyle intervention or placebo.
A review of the data was the top story in cardiology last week.
Another top story explored efforts to improve access to sleep apnea care through cardiology practice accreditation. Raman Malhotra, MD, FAASM, the president of the American Academy of Sleep Medicine, said that cardiologists are “in a unique position” to improve the screening and diagnosis of obstructive sleep apnea, which is common among patients with CVD.
Read these and more top stories in cardiology below:
No CV benefit with metformin, lifestyle intervention, despite diabetes prevention
In adults with prediabetes, metformin and lifestyle interventions decreased the likelihood of type 2 diabetes development but did not reduce risk for major adverse cardiovascular events compared with placebo during 21 years of follow-up, data show. Read more.
Improving access to sleep apnea care through cardiology practice accreditation
Patients with CVD are 40% to 80% more likely to have comorbid obstructive sleep apnea, which in severe cases can cause them to stop breathing hundreds of times a night. Read more.
Very high HDL ‘red flag’ for all-cause, CV death risk in adults with CAD
In adults with CAD, those with HDL of 80 mg/dL or greater are nearly twice as likely to die of any cause compared with those with HDL between 40 mg/dL and 60 mg/dL, according to an analysis of two large biobank databases. Read more.
Polygenic component associated with HCM risk, offering prediction tool
Rare and common genetic variants contribute substantially to susceptibility to hypertrophic cardiomyopathy in the general population and can help improve risk prediction beyond clinical factors, researchers reported. Read more.
Low income tied to mortality risk after STEMI hospitalization
Patients with low household income who presented with STEMI faced greater risk for inpatient mortality, longer hospital stay and need for invasive mechanical ventilation vs. patients with higher income, data show. Read more.